Cargando…
Development and validation of a 4-gene combination for the prognostication in lung adenocarcinoma patients
Objective: To identify a multi-gene prognostic factor in patients with lung adenocarcinoma (LUAD). Materials and methods Prognosis-related genes were screened in the TCGA-LUAD cohort. Then, patients in this cohort were randomly separated into training set and test set. Least absolute shrinkage and s...
Autores principales: | Yin, Xiao-Hong, Yu, Li-Ping, Zhao, Xiao-Hong, Li, Qin-Mei, Liu, Xiao-Ping, He, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052877/ https://www.ncbi.nlm.nih.gov/pubmed/32194805 http://dx.doi.org/10.7150/jca.37003 |
Ejemplares similares
-
Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
por: Liu, Xiao-Ping, et al.
Publicado: (2019) -
Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma
por: Yu, Dong-Hu, et al.
Publicado: (2020) -
Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma
por: Feng, Zhenxing, et al.
Publicado: (2022) -
Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022) -
Expression and clinical significance of A‐kinase anchor protein 4 in lung adenocarcinoma tissue
por: Li, Hong‐Mei, et al.
Publicado: (2015)